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Remodeling of experimental arteriovenous
fistula with increased matrix metalloproteinase
expression in rats
Chih-Yang Chan, MD,a,b Yih-Sharng Chen, MD, PhD,c Ming-Chieh Ma, PhD,d and
Chou-Fong Chen, PhD,b Panchaio, Taipei, and Hsinchuang, Taiwan
Objective: Venous dilatation and wall thickening are part of the maturation of an arteriovenous fistula (AVF). However,
the underlying mechanism of AVF remodeling remains unknown. We therefore studied whether matrix remodeling
elicited by matrix metalloproteinases (MMPs) may contribute to AVF maturation.
Methods: A femoral AVF model in rats was established by invagination of the distal end of the left femoral artery into the
femoral vein after venotomy (fistula group). In the sham group, the left femoral artery was cut, but venous invagination
was not performed. Changes in the hemodynamics and the diameter of the iliac vein were studied on days 3, 14, and 28,
then the iliac vein was removed and examined for changes in wall thickness and expression of MMP-2 and MMP-9, type
4 tissue inhibitor of metalloproteinases (TIMP-4), and collagen I and III by immunohistochemical staining or Western
blotting.
Results: Femoral AVF resulted in a sixfold increase in blood flow in the fistula iliac vein and a gradual, but significant,
increase in the thickness of the intima and media and marked up-regulation of MMP-2 and MMP-9, down-
regulation of TIMP-4, as well as degradation of collagens I and III. The collagen I/III ratio was significantly higher
in the 14-day fistula group (1.44  0.32) than in the sham group (0.82  0.15) and was even higher in the 28-day
fistula group (1.76  0.21).
Conclusion: The present results confirmed our hypothesis that a high blood flow rate in the fistula vein affects the
expression of MMPs and TIMP-4, resulting in the remodeling or maturation of the AVF. Remodeling is associated with
degradation of collagen, with an increase in the collagen I/III ratio. ( J Vasc Surg 2007;45:804-11.)
Clinical Relevance: Understanding the mechanisms of fistula maturation will focus future studies of targeted interven-
tions to improve the rate of fistula maturation and increase the number of dialysis patients with a functioning autogenous
fistula.Most patients with end-stage renal disease require he-
modialysis. An arteriovenous fistula (AVF) is the preferred
access for this. After its surgical creation, the fistular vein
immediately faces a tremendous blood flow and the venous
lumen is gradually dilated and the wall thickened, produc-
ing a fistular vein that can be routinely needled and deliver
sufficient blood flow for dialysis.
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804These AVF remodeling processes are termed the mat-
uration of a fistula. Fistula maturation requires a compliant
and responsive vasculature capable of dilating in response
to the increased velocity of the blood flowing into the
newly created low-resistance circuit. Successful maturation
to a high-volume-flow circuit capable of sustaining hemo-
dialysis typically occurs within the first few weeks after
creation.1
A fistular vein faces a different environment from that
faced by a vein graft created in an arterial system. The
increase in the flow may be large, but the increase in
pressure in the vein is less than that in a vein graft created in
the arterial system. Nevertheless, the cellular and extracel-
lular components of the venous wall of a fistula are still
slightly stretched when the vein is distended by the arterial
inflow.
Matrix metalloproteinases (MMPs) belong to a group of
zinc-dependent proteases and degrade most extracellular ma-
trix (ECM) proteins, such as collagen and elastin, this being a
prerequisite for vascular remodeling. In the blood vessel,
oveno
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vessels by breaking down the ECMwhile newmatrix is being
synthesized.2 These processes require coordinated changes in
mitogenic signaling and the degradation and reorganization
of the ECM by MMPs. MMP-2 and MMP-9 (gelatinase A
and B, respectively) are especially important regulators of
vascular architecture3 because of their specificity for elastin
and collagen.
Changes in protein level or activity of MMP-2 and
MMP-9 have been suggested to be the main changes in
MMPs contributing to vascular remodeling.4,5 Flow in-
crease, mechanical distention and stretch, vascular injury,
oxidative stress, and inflammation are potent stimuli for
their activation.6,7 Mechanical stretch and vascular injury of
an artery8,9 or a venous graft in the arterial system10 are
known to activate MMPs and are associated with vascular
smooth muscle cell migration and vascular remodeling.9,11
MMP activity can be regulated at several levels, includ-
ing the interactions of MMPs with endogenous tissue
inhibitors of MMPs (TIMPs).12 TIMP-4 was recently
cloned and characterized with a suggested role in the rat
carotid artery damaged by balloon inflation and in mice
arteries treated with nonradioactive coils.13,14 It inhibits
MMP-9 and shows a particular interaction with MMP-2,
although unlike TIMP-2, it does not promote pro-MMP-2
activation.15-17 TIMP-4 transcripts are abundant in the
heart, but its role in cessation of smooth muscle cell migra-
tion and onset of collagen degradation suggest a possible
cardiovascular specificity in regulating vascular remodeling.
Because the molecular mechanisms involved in the
maturation of a venous graft in the AVF are unknown, we
Fig 1. Schematic diagram of the arteriovenous fistula
femoral artery (a) and vein (v) were carefully dissected.
were clamped and the distal ends ligated using 4-0 silk. (c
was created using iris scissors under a dissecting microsc
constructed by invagination of the cut end of the artery
prevent the artery from detaching after reflow. (f) The c
the blood in the vein quickly turned bright red and the
conditions. (h) The vascular structures for the left arteristudied the vein in a fistula system in a rat model rather thana graft in an arterial system. We hypothesized that the
pressure or flow increase in the AVF, or both, in the absence
of any contribution from surgical injury and healing, might
regulate MMP function, which may contribute to the
changes in venous wall thickening and the maturation of
the AVF.
MATERIAL AND METHODS
Female Wistar rats (200 to 250 grams) were housed at
a constant temperature and on a light/dark cycle (light
from 0700 to 1800). All animal experiments and animal
care were performed in accordance with the Guide for the
Care and Use of Laboratory Animals (National Research
Council of the National Academy of Sciences, 1997). Two
groups of animals were used. Both groups underwent one
side femoral artery ligation. The fistula group then under-
went femoral arteriovenous connection in the left limb, but
the sham group did not. Temporal changes in vessel thick-
ness and biochemical changes were studied in the two
groups at days 3, 14, and 28.
Surgical procedure for arteriovenous fistula. A
schematic diagram of the femoral vascular shunting is
shown in Fig 1. AVF was performed on rats anesthetized by
intraperitoneal injection of a combination of ketamine hy-
drochloride (60 mg/kg) and pentobarbital sodium (15
mg/kg), 5 mg/kg of pentobarbital being given subse-
quently if needed. To prevent blood coagulation, heparin
(500 U/kg of body weight) was administered intraperito-
neally before the vessel was clamped.
Determination of blood flow or pressure changes in
the vein. On the day of the experiment, the rats were
l. (a) After an incision was made in the left groin, the
he proximal ends of both vessels close to the abdomen
distal end of the femoral artery was cut and a venotomy
(d) The anastomosis of the femoral artery and vein was
the vein. (e) Ligature using 8-0 silk was performed to
on the proximal end of the artery was then released and
expanded. (g) The groin was then closed under aseptic
us shunt are shown.mode
(b) T
) The
opy.
into
lamp
veinanesthetized with intraperitoneal pentobarbital sodium (50
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tion for spontaneous ventilation and measurement of the
systemic blood pressure, respectively, a midline laparotomy
was performed to expose the lower abdomen vessels. The
external diameter of the left iliac vein was measured using a
ruler. The iliac veins (at least 2 cm cephalad) and inferior
vena cava (IVC) were then isolated from the surrounding
tissue to measure the blood flow using a flowmeter (Tran-
sonic, Ithaca, NY). The pressure in the veins was measured
by direct puncture with a 30# needle connected to a
polyethylene tubing (PE)-10 tube and pressure transducer.
The pressure and flow were found to be similar at the sites
of the AV shunt in the femoral vein and 2 cm away from the
anastomosis in the iliac vein (data not shown).
Sampling of vein segments. After the in vivo mea-
surements, the iliac veins were removed after transcardiac
perfusion at 4°C with 800 mL of phosphate-buffered saline
(PBS), pH 7.4, as described previously.18 Half of the vein
was post-fixed in 4% paraformaldehyde in PBS for histo-
logic examination or immunostaining. The remaining
tissue was frozen at –80°C until used for Western blot
analysis.
Histologic examination and immunohistochem-
istry. After post-fixation for 24 hours, the specimens were
immersed overnight at 4°C in a paraformaldehyde solution
containing 20% sucrose, then the tissue was embedded in
optimal cutting temperature medium, and 5-m-thick sec-
tions prepared as described previously.18 Some of the tissue
slices were prepared for staining with hematoxylin and
eosin to determine the thickness of the intimal and medial
layers using imaging software with a microruler (Spot,
Diagnostic Instruments, Sterling Heights, Mich).
For immunohistochemical staining, sections were
treated as described previously.18 In brief, slides were incu-
bated at room temperature with 5% skim milk. After wash-
ing, they were incubated overnight at 4°Cwithmonoclonal
mouse antibodies against MMP-2 (1:250, BioVision,
Mountain View, Calif) or MMP-9 (1:100, BioVision).
After washes, the sections were incubated at room temper-
ature for 1 hour with peroxidase-conjugated antimouse
immunoglobulin (Ig) G antibodies (BioVision). The
Table. Temporal changes in the body data and the width
fistula groups
Day 3
Sham Fistula Sh
Rats (n) 8 8 1
Body weight (g) 175  4 171  2 210
Width (mm)* ND ND 1.38
Flow (ml/min)† ND ND 2.8
Pressure (mm Hg)‡ ND ND 0.9
ND, Not determined.
*The vessel width of iliac vein.
†P  .05, compared to the corresponding sham group.
‡Blood flow rate and intravascular pressure were measured in the iliac vein.bound antibodies were visualized by incubating with acommercial DAB kit (Vector, Burlingame, Calif), and the
dark brown reaction product was examined under light
microscopy at original magnification 400 and an image
analytic system (Diagnostic Instruments).
Western blot analysis. The venous tissue was homog-
enized and a total protein sample prepared, as described
previously.19 Two vein segments pooled as one protein
sample were prepared and measured using a commercial
assay kit (Bio-Rad, Hercules, Calif), then separated by
sodium dodecyl (lauryl) sulfate gel electrophoresis, and
electrophoretically transferred to nitrocellulose membranes
(Amersham Bioscience, Piscataway, NJ). After blocking
with 5% skim milk, the membranes were incubated over-
night at 4°C with rabbit antibodies against MMP-2 (1:
1000) or MMP-9 (1:500; both from BioVision) or
TIMP-4 (1:2000, Santa Cruz), or mouse antibodies
against collagen I or collagen III (both 1:1000; Sigma, St.
Louis, Mo). The membranes were washed and incubated
for 1 hour at room temperature with horseradish peroxidase–
conjugated antirabbit IgG antibodies (Vector) or goat
antimouse IgG antibodies (Lenico, St. Louis, Mo) at an
appropriate dilution, washed, and bound antibody was
detected using a commercial electrochemiluminescence
(ECL) kit (Amersham Bioscience). The densities of the
bands with appropriate molecular masses (72 kDa for
MMP-2, 92 kDa for MMP-9, 23 kDa for TIMP-4, and 70
kDa for collagen I and III) were determined semi-
quantitatively using a densitometer.
Statistics. Numerical data are presented as themean
standard error of the mean. Differences between groups
were analyzed using an unpaired t test or one-way analysis
of variance, with a post-test using Duncan’s multiple-range
test. Differences were regarded as significant at P  .05.
RESULTS
Dilatation of the fistular vein. As summarized in the
Table, the two groups had similar body weight and weight
gain. On day 14 after creation of the AVF, the mean
external diameter of the iliac vein on the fistular side was
significantly increased compared to that on the ipsilateral
side in sham rats at the same time point. On day 28, the
hemodynamics of the iliac vein in the sham and
Day 14 Day 28
Fistula Sham Fistula
11 8 8
209  4 240  5 234  7
4 1.76  0.08† 1.37  0.05 2.32  0.10†
18.9  5.3† 2.4  0.3 17.6  3.5†
2.3  0.3 0.6  0.5 0.1  0.5and
am
1
 5
 0.0
 0.7
 0.5dilatation of the fistular vein was more pronounced, and the
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sham rats or on day 14 fistula rats. The iliac vein in some
animals in the fistula group was enlarged to a size similar to
that of the IVC.
The blood flow in the iliac vein in the sham group at
2 cm cephalad (same level as in the fistula rats) was 3
mL/min on days 14 and 28. However, the femoral arterio-
venous connection resulted in a significant increase in flow
on days 14 and 28 to 18.9 5.3 and 17.6 3.5 mL/min,
with no significant difference between days 14 and 28. In
the fistula rats, the mean arterial pressure was similar on
days 14 (118 6 mmHg) and 28 (122 8 mmHg), but
there was a tendency (not statistically significant) to an
increase in intravascular pressure in the iliac vein on the
fistular side compared with the contralateral iliac vein. In
the fistula group, the intravascular pressure in the IVC was
0.4 0.7 mmHg on day 14 and1.8 0.9 mmHg on
day 28 (data not shown).
Increase in wall thickness. In the fistula group, a
gradual increase in the wall thickness of the fistular iliac vein
was seen (Fig 2, A). As shown in the upper panel, the mean
thickness of the intima was 9.34  1.62 m on day 3,
12.831.95 m on day 14, andr 14.79 1.83 m on day
28, all significantly different when compared with sham rats
at the same time-points (day 3, 6.99  0.21 m; day 14,
8.22  0.34 m; day 28, 8.68  0.75 m). The thick-
ness of the media (middle panel) was also significantly
increased on days 14 (5.38  0.44 vs 8.51  0.36 m)
and 28 (5.67  0.15 m vs 10.42  0.41 m).
Hyperplasia of both the intimal and medial layers con-
tributed to the thickening of the venous wall. The intima-
to-media thickness ratio (bottom panel) was unchanged at
any time-point compared with the sham group. Fig 2, B
Fig 2. Changes in the thickness of the layers in the iliac v
and media and the intima/media thickness ratio of the le
with the corresponding sham group. B, Representative v
fistula rats at day 14 or 28. Note that the vessel walls on d
the contralateral right side in the same animal or on the
400. The horizontal bar indicates 20 m.shows representative pictures of the wall thickness on days14 and 28. In the left iliac vein of the fistula group (right
panels), the intima and media thickened simultaneously
and in a time-dependent manner compared with the sham
group (left panels). The wall thickness of the right iliac vein
in sham and fistula rats was similar.
Upregulation of matrix metalloproteinase 2 and 9
in fistular veins. Because MMPs are responsible for vas-
cular remodeling, we measured the levels of MMP-2 and
MMP-9 in the iliac vein grafts to see whether changes in
their expression correlated with AVF maturation. Western
blot analysis showed that levels of MMP-2 (Fig 3, A) and
MMP-9 (Fig 3, B) increased with time after AVF compared
with the sham group (P  .05). MMP-2 and MMP-9
expression was negligible in sham rats, with no significant
difference between the two iliac veins at the same time
point or between the values for the left iliac vein at the time
points of 14 and 28 days (data not shown); therefore,
pooled day 14 and 28 samples were used as controls.
Linear regression analysis showed significant correla-
tions between the levels of theMMPs and the wall thickness
of the iliac vein (R  0.67 for MMP-2 and R  0.32 for
MMP-9; Fig 3, C). We localized the MMPs in situ in the
venous wall of sham and fistula rats by immunohistochem-
istry. Fig 3, D shows representative staining for both
MMP-2 andMMP-9 in representative sham and fistula rats
at day 28. Little MMP-2 expression was seen in the sham
rat (left upper panel), but levels were markedly increased in
the fistular vein in the thickened intima and media (right
upper panel). MMP-9 expression was seen in the intimal
and subintimal tissues in the sham rat (left lower panel), but
was greatly increased in the fistular rat (right lower panel).
Temporal changes in the amounts of tissue inhibi-
tor of metalloproteinase 4 and collagens. We further
, Temporal changes in the mean thickness of the intima
vein in the sham and fistula groups. *P .05 compared
segments of the right and left iliac veins from sham and
and 28 are thicker than at the same time point on either
side in sham rats. Reduced from original magnificationein.A
ft iliac
essel
ays 14
sameanalyzed TIMP-4 expression because TIMP-4 selectively
signals and 100 m.
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via its N-terminal region.3 As shown in Fig 4, A, compared
with the sham group (day 14 and 28 samples pooled),
TIMP-4 levels in the fistula group were gradually down-
regulated, a significant difference being seen at day 28.
The above results clearly showed that MMP expression
was increased and TIMP-4 expression decreased, suggest-
ing that these changes may contribute to the thickening of
the fistular vein subjected to a high blood flow. Since
MMPs are the principal matrix enzymes cleaving fibrillar or
nonfibrillar structures, we investigated whether the ob-
served the changes in collagens were associated with in-
creased MMP activity. As shown in Fig 4, B, the amount of
collagen I in the fistula group was significantly higher on
day 14, but significantly lower on day 28 than in the sham
group (pooled samples from days 14 and 28). Collagen III
expression in the fistula group was unchanged on day 14
but showed a significant decrease on day 28. Of interest,
the collagen I/III ratio was 0.82 0.15 in the sham group
and was significantly increased (1.44  0.32) in the fistula
group at day 14, and further increased (1.76 0.21) in the
Fig 4. A, Decreased levels of tissue inhibitor of matrix
metalloproteinase-4 and B, collagen I/III. Representative blots
from six (TIMP-4) and four (collagen I and III) rats. The bar
graphs show that the change to TIMP-4/actin density unit (DU)
ratio and collagen I or III/actin DU ratio. *P  .05 compared
with the sham group (pooled day 14 and 28 samples).Fig 3. Upregulation of matrix metalloproteinase (MMP) 2 and
9. A, Changes in the expressions of MMP2 and B,MMP9 in six
rats examined by Western blotting. The bar graphs show that
the change to MMP2 or MMP9/actin density unit (DU) ratio.
*P  .05 compared with the sham group (days 14 and 28
pooled). C, Linear regression shows that the amounts of MMP2
and 9 are positively correlated with the thickness of the intima.
D, Representative micrographs show the location of MMP2 and
MMP9 in situ by immunohistochemical staining at 28 days in
sham rat and a fistula rat. Reduced from original magnification
400. The black arrows and horizontal bar indicate positivefistula group at day 28.
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The present study showed the effect of arteriovenous
hemodynamics on fistular vein remodeling and enhanced
MMP in a rat AVF model. The rat model presented here
has several novel features. First, it showed native fistula
hemodynamics, with a high flow and low pressure resem-
bling those seen in a clinically constructed AVF for hemo-
dialysis. There was both outward geometric remodeling
(dilatation) and inward remodeling (shrinkage) of the vein
that correlated well with the clinical maturation of an AVF.
Second, we showed that a great increase in flow and
minor pressure distension of the vein increased neointima
formation in the fistular vein 28 days, the period often
required for the AVF maturation in human hemodialysis.20
Third, the vascular remodeling was associated with
collagen degradation and an increase in the collagen I/III
ratio. This rapid (28 days) upregulation of MMPs, asso-
ciated with a decrease in TIMP-4, might account for the
modification of the ECM seen in the venous segment of the
AVF.
Several mechanical factors can influence vessel remod-
eling. The surgical stresses of dissection, distension, and
anastomosis increase MMP activity and stimulate neointi-
mal formation, which predisposes the vein graft to exten-
sive remodeling.21-24 Wound healing processes, inflamma-
tion, and possible later infection also have a profound effect
on the vessels under the wound.25 Our model showed
direct evidence of the effect of simple hemodynamic forces
on levels of MMPs and TIMP-4, collagen deposition, and
remodeling of the fistular vein in the absence of any effect
caused by surgical wounding. However, our present animal
model of AVF involves the iliac vein, which belongs to the
deep venous system rather than the superficial system used
in the clinic for uremic patients, and these two systems
might have different phenotype presentations.
High blood flow affects matrix metalloproteinases
in arteriovenous fistula maturation. Significant venous
dilatation and increased flow in the fistula were seen in the
present study. The increase in fistula blood flow was seen
immediately after surgical anastomosis (data not shown)
and was followed by a gradual increase to maximal blood
flow on day 14. These findings are consistent with clinical
findings of the human fistula, which continues to dilate for
many months.20,26 Wong et al26 showed that the average
luminal diameter is increased by 56% on day 1 after creation
and increases to 123% of control at 12 weeks. Similarly,
Corpataux et al20 found that the vein lumen of an AVF
increased by 86% at 1 week and 179% at 12 weeks. Our
AVFs also exhibited continuous dilatation, but the extent
was less than in the human studies, only increasing by about
28% and 68% of sham levels on day 14 and 28. This
difference can be explained by the fact that the human
superficial AVF dilates more easily than the deep AVF
created in our rat model.
Venous histologic changes, characterized by varying
degrees of neointimal hyperplasia and thickening of the
venous wall, were seen in the AVF group at days 14 and 28.In a study of aortocaval fistula, Nath et al27 showed venous
thickening, evidenced by smooth muscle cell proliferation
and ECM deposition. In the clinic, no change in the
intima-media thickness of the venous wall was detected by
ultrasound imaging after fistular creation, but a marked
increase in the calculated venous wall cross-sectional area
was observed by Corpataux et al.20 These authors sug-
gested that the venous remodeling of the forearm takes the
form of an eccentric hypertrophy, resulting in an increase in
vascular mass.
In the present study, high blood flow through the
fistular vein was correlated with upregulation of MMP-2
and MMP-9 and an increase in wall thickness and luminal
diameter. Blood flow in the fistular iliac vein was increased
sixfold in the day 14 fistula, and this was maintained to day
28 (Table), whereas levels of MMP-2 increased tremen-
dously and those of MMP-9 significantly at the same time
points (Fig 3, A and B). Hemodynamic changes, mechan-
ical injury, or inflammation may trigger vascular remodel-
ing by regulation of the levels and activation of MMPs.1,9
The study of Pasterkamp et al22 showing increases in
MMP-2 and MMP-9 messenger RNA (mRNA) levels and
enzymatic activity have been performed on the fistular
artery rather than the vein. In an AVF model in which a
side-to-side shunt was created between the carotid artery
and the jugular vein for 7 days in rabbits, Sho et al28 showed
that the flow increase in the artery correlated with prolifer-
ation of the neointima and media and a marked and pro-
longed increase in MMP-2 mRNA levels, whereas MMP-9
mRNA levels were high on day 2, then decreased.
Increased MMP-2 and MMP-9 protein levels have also
been reported in a pig model of vein graft exposure to the
arterial circulation.29 Southgate et al10 used saphenous vein
into carotid artery interposition grafting in a pig model and
showed increased production of MMP-2 and MMP-9 pro-
teins during the period of neointima formation and smooth
muscle cell proliferation in the experimental vein grafts.
Sharony et al30 found that both inflammatory mediators
and extracellular signal-regulated kinases affected MMP-2
andMMP-9 protein expression in the arterialized vein graft
in a canine model. Similar findings of neointimal hyperpla-
sia were obtained in a study of a human aortocoronary vein
graft.31
Taken together, these studies suggest that a high flow
and shear stress can cause endothelial cells and vascular
smooth muscle cells in an artery or a vein graft to express
MMP-2 and MMP-9, resulting in neointimal hyperplasia
and vessel enlargement. Our study showed that exposure of
a fistular vein to a high blood flow without the substantial
injury of grafting or surgical dissection also resulted in
increased levels of MMP-2 and MMP-9, similar to the
previous findings on arteries or vein grafts. We therefore
suggest that a high blood flow causes fistular venous dila-
tation and wall thickening, probably by the mechanism
associated with MMP upregulation and TIMP downregu-
lation.
Effect of pressure changes on MMP expression. In
a human AVF, the venous pressure increases to about 30%
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typically attains 40% to 60% of the maximal blood flow
within days and maximal blood flow is reached within
weeks.20,26 We did find a marked increase in blood flow in
the rat model fistular vein 28 days, but not an increase in
the intravascular pressure in the segment of vein 2 cm away
from the anastomosis (Table).
Elevation of the transmural and pulsatile pressure has
been proposed as a factor up-regulating the matrix-
degrading activity of MMPs.10,24,32 However, our study
in an animal model of native fistula circulation showed
insignificant changes in the intravascular pressure in the
venous segment of the AVF, and we were unable to find any
correlation between transmural pressure and MMP expres-
sion (data not shown). This low-pressure circuit in the rat
iliac vein is consistent with findings in the human wrist AVF
that the venous pressure increase is limited and appears not
to be a contributing factor in the process of venous hyper-
trophy.20
Because the fistular vein in the present study was a
low-pressure circuit, the metabolism of ECM proteins will
be different from that seen in studies on arterial remodeling
in human subjects with hypertension. Several studies
showed increased TIMP-1 activity and lower degradation
of collagen I in hypertensive patients with left ventricular
hypertrophy or in patients with essential hypertension and
concluded that systemic extracellular degradation of colla-
gen I is depressed.23,33,34 The present study did not mea-
sure the activity of any of the proteins or measure collagen
production or degradation.
In our AVF model, levels of MMPs increased, levels of
TIMP-4 decreased gradually (Fig 4, A), and collagens I and
III were degraded after 28 days, suggesting that a high
blood flow and a low pressure produces less tensile stress
and that collagens were degraded in the venous segment for
the purpose of vascular dilatation. However, increased
MMP expression was seen at 14-day remodeling associated
with only a minor change in TIMP-4 and probably no
collagen degradation was seen at the same time point,
suggesting that factors other than TIMPmay contribute to
the changed MMP levels.
Effect of collagen degradation. An altered collagen
I/III ratio, with an increase in collagen type III, has been
claimed to reduce the mechanical strength of connective
tissues.25 Rosch et al35 also found that the type I procolla-
gen mRNA/type III procollagen mRNA ratio is decreased
in patients with primary hernia. In the sham group in the
present study, we showed that the collagen I/III ratio
was 1.0 in a normal thin-walled vein in the low-pressure
circulation, whereas the collagen content changed and the
collagen I/III ratio increased in the fistular vein facing a
high flow on days 14 and 28 (Fig 4, B).
Although the absolute amounts of collagen I and III in
the fistular vein decreased at day 28, levels of collagen III
decreased more quickly than those of collagen I (second
panel in Fig 4, B), and the collagen I/III ratio therefore
remained elevated. This change in the phenotype of colla-
gens in the ECM, together with the dilatation of the venouslumen and the thickening of venous wall, might associate
with the AVF maturation.
CONCLUSION
The results of the present study confirmed our hypoth-
esis that up-regulation of MMP-2 and MMP-9 and down-
regulation of TIMP-4 are involved in the remodeling or
maturation of an AVF, affecting both the outward dilata-
tion and vessel wall thickening. This also suggests that
MMP is one of the biochemical mechanisms involved in the
flow-induced fistular dilatation and cell proliferation in
veins. The increased collagen I/III ratio in the ECM and
the thickening of the venous wall strengthen the vessel for
hemodialysis access.
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